Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NALT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GABRA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101929122 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ARHGAP20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM30B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928973 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UNC13D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR5A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPBD1P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXC11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on